Article Text

other Versions

PDF
Antigliadin antibodies in Spinocerebellar Ataxia Type 2 Cuban patients
  1. Luis Enrique Almaguer Mederos (leam{at}cristal.hlg.sld.cu)
  1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
    1. Yobanis Rodríguez Almira
    1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
      1. Edilberto Martínes Góngora
      1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
        1. Dennis Almaguer Gotay
        1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
          1. Yanetza González Zaldivar
          1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
            1. Ricardo Echevarria Pupo.
            1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
              1. Gilberto Sánchez Cruz.
              1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
                1. Julio Monte Brown
                1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
                  1. Dany Coello Almarales.
                  1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba
                    1. Luis Velázquez Pérez.
                    1. Center for the Investigation and Rehabilitation of Hereditary Ataxias (CIRAH) “Carlos J. Finlay”, Cuba

                      Abstract

                      The relevance of gluten sensitivity in hereditary ataxia pathogenesis is unclear. Objective: To evaluate the significance of antigliadin antibodies levels for spinocerebellar ataxia type 2. Methods: We determined antigliadin antibodies in 64 spinocerebellar ataxia type 2 patients and in 65 healthy matched controls. The clinical assessment was carried out using the International Cooperative Ataxia Rating Scale and CAG repeat number was assessed by PCR. Results: Antibodies were positive in 23,4% of the ataxia patients and 9,09% of the controls. Statistical comparison using (chi)2 test with Yates’s correction reveal significant differences between these two groups (?2 = 3,94; p= 0,047). The same was obtained for strongly positive antigliadin antibodies (?2 = 4,62; p= 0,032). There were not significant differences between AGA positive and AGA negative patients in age at onset, disease duration, ataxia score, or CAG repeat number; neither in the prevalence of gastrointestinal symptoms, prevalence of wheat intolerance, or body weight. These results demonstrates an association between antigliadin antibodies serum levels and SCA2. However, more work has to be done to clarify the clinical consequences of such an association.

                      • Antigliadin antibodies
                      • Gluten sensitivity
                      • Neurotoxicity
                      • Spinocerebellar ataxia type 2
                      • polyglutamine proteins

                      Statistics from Altmetric.com

                      Request permissions

                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.